Literature DB >> 10708436

Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.

D Camerini1, H P Su, G Gamez-Torre, M L Johnson, J A Zack, I S Chen.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) patient isolates and molecular clones were used to analyze the determinants responsible for human CD4(+) thymocyte depletion in SCID-hu mice. Non-syncytium-inducing, R5 or R3R5 HIV-1 isolates from asymptomatic infected people showed little or no human CD4(+) thymocyte depletion in SCID-hu mice, while syncytium-inducing (SI), R5X4 or R3R5X4 HIV-1 isolates from the same individuals, isolated just prior to the onset of AIDS, rapidly and efficiently eliminated CD4-bearing human thymocytes. We have mapped the ability of one SI HIV-1 isolate to eliminate CD4(+) human cells in SCID-hu mice to a region of the env gene including the three most amino-terminal variable regions (V1 to V3). We find that for all of the HIV-1 isolates that we studied, a nonlinear relationship exists between viral replication and the depletion of CD4(+) cells. This relationship can best be described mathematically with a Hill-type plot indicating that a threshold level of viral replication, at which cytopathic effects begin to be seen, exists for HIV-1 infection of thymus/liver grafts in SCID-hu mice. This threshold level is 1 copy of viral DNA for every 11 cells (95% confidence interval = 1 copy of HIV-1 per 67 cells to 1 copy per 4 cells). Furthermore, while SI viruses more frequently achieve this level of replication, replication above this threshold level correlates best with cytopathic effects in this model system. We used GHOST cells to map the coreceptor specificity and relative entry efficiency of these early- and late-stage patient isolates of HIV-1. Our studies show that coreceptor specificity and entry efficiency are critical determinants of HIV-1 pathogenesis in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708436      PMCID: PMC111820          DOI: 10.1128/jvi.74.7.3196-3204.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  The nef gene from a long-term HIV type 1 nonprogressor.

Authors:  D R Premkumar; X Z Ma; R K Maitra; B K Chakrabarti; J Salkowitz; B Yen-Lieberman; M S Hirsch; H W Kestler
Journal:  AIDS Res Hum Retroviruses       Date:  1996-03-01       Impact factor: 2.205

2.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

3.  HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor.

Authors:  Y Feng; C C Broder; P E Kennedy; E A Berger
Journal:  Science       Date:  1996-05-10       Impact factor: 47.728

4.  The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection.

Authors:  F Cocchi; A L DeVico; A Garzino-Demo; A Cara; R C Gallo; P Lusso
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

5.  Human immunodeficiency virus strains differ in their ability to infect CD4+ cells expressing the rat homolog of CXCR-4 (fusin).

Authors:  O Pleskoff; N Sol; B Labrosse; M Alizon
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.

Authors:  B J Doranz; J Rucker; Y Yi; R J Smyth; M Samson; S C Peiper; M Parmentier; R G Collman; R W Doms
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

7.  Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard.

Authors:  B Poon; J B Jowett; S A Stewart; R W Armstrong; G M Rishton; I S Chen
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

8.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.

Authors:  H Kaneshima; L Su; M L Bonyhadi; R I Connor; D D Ho; J M McCune
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  In vivo pathogenic properties of two clonal human immunodeficiency virus type 1 isolates.

Authors:  B D Jamieson; S Pang; G M Aldrovandi; J Zha; J A Zack
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Authors:  R I Connor; K E Sheridan; D Ceradini; S Choe; N R Landau
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

View more
  25 in total

1.  Characterization of a thymus-tropic HIV-1 isolate from a rapid progressor: role of the envelope.

Authors:  Eric G Meissner; Karen M Duus; Feng Gao; Xiao-Fang Yu; Lishan Su
Journal:  Virology       Date:  2004-10-10       Impact factor: 3.616

2.  Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.

Authors:  R M Scoggins; J R Taylor; J Patrie; A B van't Wout; H Schuitemaker; D Camerini
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Extensive syncytium formation mediated by the reovirus FAST proteins triggers apoptosis-induced membrane instability.

Authors:  Jayme Salsman; Deniz Top; Julie Boutilier; Roy Duncan
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  R5 human immunodeficiency virus type 1 infection of fetal thymic organ culture induces cytokine and CCR5 expression.

Authors:  Shailesh K Choudhary; Neelima R Choudhary; Katherine C Kimbrell; Jonathan Colasanti; Argyrios Ziogas; David Kwa; Hanneke Schuitemaker; David Camerini
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant.

Authors:  Hiroshi Mohri; Nicole Prada; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

6.  Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous.

Authors:  Tatsuhiko Igarashi; Charles R Brown; Russell A Byrum; Yoshiaki Nishimura; Yasuyuki Endo; Ronald J Plishka; Charles Buckler; Alicia Buckler-White; Georgina Miller; Vanessa M Hirsch; Malcolm A Martin
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Thymic lesions in cats infected with a pathogenic molecular clone or an ORF-A/2-deficient molecular clone of feline immunodeficiency virus.

Authors:  R M Norway; P C Crawford; C M Johnson; A Mergia
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Separation of human immunodeficiency virus type 1 replication from nef-mediated pathogenesis in the human thymus.

Authors:  K M Duus; E D Miller; J A Smith; G I Kovalev; L Su
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

9.  Human immunodeficiency virus persistence and production in T-cell development.

Authors:  Kevin B Gurney; Christel H Uittenbogaart
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

10.  Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms.

Authors:  Aprille Seidel; Ying Ye; Lesley R de Armas; Maira Soto; William Yarosh; Renee A Marcsisin; Dat Tran; Michael E Selsted; David Camerini
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.